Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
MIRM
Stock Latest News
Ratings
Mirum Therapeutics: Strong FOP Data and Priority Review Support Buy Rating and Unchanged $150 Price Target
19m ago
MIRM
Premium
Ratings
Buy Rating Reiterated on Mirum Pharmaceuticals as Zilurgisertib Data De-Risk Pipeline; $145 Price Target Unchanged with ~46% Upside Potential
1h ago
MIRM
Premium
The Fly
Mirum Pharmaceuticals price target raised to $146 from $140 at Citizens
2h ago
MIRM
Premium
The Fly
Incyte, Mirum announces Phase 2 results from Cohort 1 of Progress study
15h ago
INCY
MIRM
Premium
The Fly
Mirum Pharmaceuticals price target raised to $150 from $140 at Morgan Stanley
4d ago
VIR
MIRM
Premium
The Fly
Vir Biotechnology price target raised to $27 from $23 at Morgan Stanley
4d ago
VIR
MIRM
Premium
The Fly
Incyte, Mirum to present Phase 2 results from PROGRESS study at ENDO 2026
11d ago
INCY
MIRM
Premium
Company Announcements
Mirum Expands Long-Term Safety Data for Livmarli in Rare Pediatric Liver Diseases
12d ago
MIRM
Premium
The Fly
Mirum Pharmaceuticals initiated with a Buy at Citi
13d ago
MIRM
Premium
Ratings
Mirum Pharma Earns Buy Rating on Strong Volixibat Phase 2b PSC Data and De-Risked Regulatory Path
14d ago
MIRM
Premium
The Fly
Mirum announces new data from its rare liver disease programs at EASL
15d ago
MIRM
Premium
Company Announcements
Mirum Pharmaceuticals Balances Rapid Growth and Heavy Spend
26d ago
MIRM
Premium
The Fly
Mirum Pharmaceuticals initiated with an Outperform at Wolfe Research
27d ago
MIRM
Premium
Company Announcements
Mirum Pharmaceuticals Issues $690 Million Convertible Senior Notes
28d ago
8K
MIRM
Premium
The Fly
Mirum Pharmaceuticals announces $600M convertible senior notes offering
1M ago
MIRM
Premium
The Fly
Mirum Pharmaceuticals price target raised to $165 from $164 at Raymond James
1M ago
MIRM
Premium
The Fly
Mirum Pharmaceuticals price target raised to $145 from $125 at TD Cowen
1M ago
MIRM
Premium
The Fly
Mirum Pharmaceuticals price target raised to $142 from $128 at RBC Capital
1M ago
MIRM
Premium
The Fly
Mirum Pharmaceuticals price target raised to $129 from $112 at Baird
1M ago
MIRM
Premium
The Fly
Mirum Pharmaceuticals price target raised to $136 from $130 at Stifel
1M ago
MIRM
Premium
The Fly
Mirum Pharmaceuticals price target raised to $138 from $135 at Evercore ISI
1M ago
MIRM
Premium
The Fly
Mirum Pharmaceuticals price target raised to $185 from $175 at H.C. Wainwright
1M ago
MIRM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
